Treatment Stories
696 articles
This Versus That: Words to Know
Confused about some of the similar-sounding terms you are hearing during pancreatic cancer treatment? Our list of words to know can help.
Surprising Clinical Trial Results in Pancreatic and Rectal Cancer
Let’s Win Scientific Advisory Board Chair Dr. Allyson Ocean explains the surprising clinical trial results in pancreatic and rectal cancers.
mRNA Vaccine Trial Expands to Numerous Locations
The mRNA vaccine trial spearheaded by Dr. Vinod Balachandran has opened in more locations in the US and around the world.
ASCO 2023: Pancreatic Cancer Research Update
The pancreatic cancer research reports from ASCO 2023 focused on different chemotherapy combinations, including immunotherapy.
Phase II mRNA Vaccine Trial Opens
The mRNA vaccine phase II clinical trial, led by Dr. Vinod Balachandran, has opened at Memorial Sloan Kettering, with other locations soon to come.
Pancreatic Cancer Research Highlights from ASCO Annual Meeting
The 2025 ASCO meeting featured pancreatic cancer research including a new treatment modality and a new treatment combination.
Exercise Before, During, and After Pancreatic Cancer Treatment Could Save Your Life
Dr. Matthew Katz explains the benefits of even the most modest amount of exercise throughout pancreatic cancer treatment.
Comparing Two Types of Radiotherapy for Pancreatic Tumors that Cannot Be Surgically Removed
Researchers are comparing standard radiotherapy treatment with a newer type of radiation that uses heavy ions, for nonsurgical pancreatic cancer patients.
Let’s Win: Innovative Online Community Offers Guidance to Patients With Pancreatic Cancer and Their Families
The ASCO Post, a news publication of the American Society of Clinical Oncology, features Let’s Win and its mission to help pancreatic cancer patients.
High-Dose Focused Radiation after Surgical Removal of Pancreatic Tumors
A clinical trial looks at the effectiveness of stereotactic body radiation therapy in killing cancer cells in the margins after pancreatic tumor removal.
Testing the Effectiveness of Radiation and Standard Treatment
A clinical trial compares FOLFIRINOX plus stereotactic body radiation therapy (SBRT) with just FOLFIRINOX for pancreatic cancer that has spread locally.
Exploiting DNA Mutations For Pancreatic Cancer Treatment
Dr. James Cleary explains how the researchers at Dana-Farber are looking to make PARP inhibitors even more effective for pancreatic cancer patients.